Navigation Links
Frost & Sullivan Lauds LI-COR Biosciences for Developing NIR Fluorescence, One of the Most Remarkable Advancements in the Biomedical Industry
Date:9/18/2013

MOUNTAIN VIEW, Calif., Sept. 18, 2013 /PRNewswire/ -- Based on its recent analysis of the in-vivo molecular imaging market, Frost & Sullivan recognizes LI-COR Biosciences with the 2013 North American Frost & Sullivan Award for Technology Leadership for its near-infrared (NIR) fluorescence technologies. LI-COR has joined hands with various institutions and organizations to achieve a smooth interaction among instruments, kits, and reagents providers.

"As NIR can penetrate depths of several centimeters, it improves the sensitivity of images. It also enables labs to eliminate image processing for spectral unmixing, as the NIR wavelength range has low tissue autofluorescence," said Frost & Sullivan Senior Research Analyst Cecilia Van Cauwenberghe. "These natural advantages of NIR make it ideal for early detection of diseases and, eventually, enhancement of therapeutic protocols."

The appropriate targeting agents for NIR optical imaging can be selected based on well-characterization and specificity in the evaluated compounds. LI-COR Biosciences offers a range of ready-to-use IRDye optical probes capable of targeting a variety of diseases. The IRDye 800CW infrared dye, a fluorescent label developed for numerous targeting agents, including peptides, small molecules, antibodies, antibody drugs, Affibody® molecules, and viruses, has been widely adopted and cited in scientific literature. These agents are compatible with most NIR fluorescence imagers.

BrightSite™ agents, another leading optical imaging tool from LI-COR, allow researchers to begin their experiments without developing new imaging probes. BrightSite™ agents are rigorously validated to ensure high purity, affinity, and specificity.

LI-COR also developed its proprietary Pearl® Impulse Imager, which has been optimized for dual-channel NIR optical imaging. This technology, based on laser excitation, can offer visuals of smaller targets at greater depths.

LI-COR's FieldBrite™ Xi optical design is another remarkable imaging technology that provides optimized, saturation-free images in 10 seconds, thus offering ease of use, high performance, and affordable images that can be used by both inexperienced and experienced optical imaging workers. This technology does away with the need for manual exposure adjustments and repeated exposures to ensure repeatability.

The company has diversified both its biotechnology and environmental product lines. Its expertise in visible and IR markers has significantly enhanced several instruments and applications in biological research. Its proprietary technology seamlessly integrates hardware, software, and labeling technologies to help users perform novel research.

"With global presence and leadership, LI-COR Biosciences is committed to delivering novel and innovative solutions in the life sciences and preclinical industry," noted LI-COR Senior Strategic Marketing Manager, Jim Wiley. "LI-COR continues to develop outstanding technology approaches while establishing a solid collaboration network with service providers and developers, with the aim of providing its customers with well-suited solutions."

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing a technology that significantly impacts both the functionality and the customer value of new products and applications. The award lauds the relevance of the innovation to the industry.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About LI-COR Biosciences

Headquartered in Lincoln, Nebraska, and holding international presence through its offices in Germany, UK, and distribution partners in more than 60 countries, LI-COR® Biosciences is providing researchers and life sciences developers with the most innovative solutions in In vivo Molecular Imaging worldwide.

LI-COR Biosciences has been a leader in the design and manufacture of instrument systems for biotechnology and environmental research. LI-COR pioneered the development of infrared fluorescence labeling and detection systems for life science domains, such as protein analysis and DNA sequencing. LI-COR Biosciences' technology platform offers unique infrared imaging solutions for a variety of applications, including Western blotting, protein arrays, cell-based assays, and In vivo Molecular Imaging. Additionally, LI-COR instruments for photosynthesis, gas analysis, and light measurement are recognized worldwide for setting standards in plant science research and environmental monitoring.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

D. Doc Chaves
Director of Marketing Communications
P: 402-467-0750
E: doc.chaves@licor.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Lauds Adcock Ingrams Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets
2. Frost & Sullivan: Shortcomings in Medical Imaging Workflow Severely Impact Radiologists Productivity
3. Berg Receives Frost & Sullivan 2013 Drug Discovery Technology Innovation Award
4. End Users Desire for Greater Control over Production Processes Increases Adoption of SISs in Europe, Finds Frost & Sullivan
5. Frost & Sullivan: Demand for Faster Healing Spurs Sale of Advanced Wound Care and Modern Wound Closure Devices in Asia-Pacific
6. Frost & Sullivan: What are the forces pushing healthcare informatics to the next level?
7. Siemens Healthcare Takes Top Honors in Both Market Shares and Technology, Making it Frost & Sullivans Company of the Year in Interventional Radiology
8. iSonea Receives Frost & Sullivan New Product Innovation Leadership Award for its Path-Breaking Mobile Asthma Monitoring App, AsthmaSense
9. Increasing Demand from End-user Applications Boosts Asia-Pacific Antimicrobial Coatings Market, Finds Frost & Sullivan
10. Frost & Sullivan Recognizes ASCEND HiT for Providing Extensive Value Enhancement to Industry Partners and Providers through its Best-of-Breed Products
11. Frost & Sullivan Recognizes Nonin Medical with 2013 North American Pulse Oximetry Devices Product Quality Leadership Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the Phase ... an anti-P-selectin antibody, reduced the median annual rate of ... placebo (1.63 vs 2.98, p=0.010) in patients with or ... the data are being featured in the official press ... Hematology (ASH) Annual Meeting and presented during the Plenary ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with ... preventative dental services to more than 15,900 children 5 years old and younger and ... $38 million over a span of five years to Western University of Health Sciences, ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 , ... ... an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to practice ... on I learned that medicine is about more than making diagnoses and prescribing medicine,” ...
(Date:12/2/2016)... ... ... Mediaplanet is proud to announce the launch of its ... therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage their ... the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This is ...
(Date:12/2/2016)... ... December 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a ... No other wearable health technology on the market can deliver all that rejiva can. ... meaningful insights about their health than the usual heart rate and steps taken”, adds ...
Breaking Medicine News(10 mins):